Tong, Huawei http://orcid.org/0000-0002-9988-1818
Huang, Jia http://orcid.org/0000-0001-7629-9641
Xiao, Qingquan
He, Bingbing http://orcid.org/0000-0002-9790-8087
Dong, Xue http://orcid.org/0000-0002-1417-6758
Liu, Yuanhua
Yang, Xiali
Han, Dingyi
Wang, Zikang
Wang, Xuchen
Ying, Wenqin
Zhang, Runze
Wei, Yu
Xu, Chunlong http://orcid.org/0000-0003-3533-3465
Zhou, Yingsi
Li, Yanfei
Cai, Minqing
Wang, Qifang
Xue, Mingxing
Li, Guoling
Fang, Kailun
Zhang, Hainan http://orcid.org/0000-0002-1058-0462
Yang, Hui http://orcid.org/0000-0003-3590-722X
Article History
Received: 17 December 2021
Accepted: 1 July 2022
First Online: 11 August 2022
Competing interests
: H.T. discloses a patent application (PCT/CN2021/121926) related to the Cas proteins described in this manuscript. H.T. is an employee of HuiGene Therapeutics Co., Ltd. H.Z. is now an employee of HuiEdit Therapeutics Co., Ltd. H.Y. is a founder of HuiGene Therapeutics Co., Ltd. and HuiEdit Therapeutics Co., Ltd. The remaining authors declare no competing interests.